There is significant variability and underutilization of standard heart failure therapies like beta-blockers and ACE inhibitors at discharge for pediatric patients with acute decompensated heart failure.
This is the first national evaluation of prescribing trends in pediatric ADHF medication. A large degree of variability in medication use for ADHF and low rates of beta-blocker and ACE inhibitor use at discharge were identified.
Moffett et al. (Fri,) studied this question.